The University of Chicago Header Logo

Connection

John Hart to Mice

This is a "connection" page, showing publications John Hart has written about Mice.
Connection Strength

0.322
  1. Stability of varicella-zoster virus and herpes simplex virus IgG monoclonal antibodies. J Immunoassay Immunochem. 2009; 30(2):180-5.
    View in: PubMed
    Score: 0.032
  2. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clin Cancer Res. 2017 Sep 01; 23(17):5281-5291.
    View in: PubMed
    Score: 0.014
  3. Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer. Phytother Res. 2017 Jan; 31(1):90-99.
    View in: PubMed
    Score: 0.014
  4. ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer. Clin Cancer Res. 2017 Jan 15; 23(2):549-561.
    View in: PubMed
    Score: 0.013
  5. Activation of the Renin-Angiotensin System Promotes Colitis Development. Sci Rep. 2016 06 08; 6:27552.
    View in: PubMed
    Score: 0.013
  6. Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model. Carcinogenesis. 2016 07; 37(7):731-739.
    View in: PubMed
    Score: 0.013
  7. X-ray fluorescence microscopy demonstrates preferential accumulation of a vanadium-based magnetic resonance imaging contrast agent in murine colonic tumors. Mol Imaging. 2015; 14.
    View in: PubMed
    Score: 0.012
  8. The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer. Clin Cancer Res. 2014 Nov 15; 20(22):5848-5859.
    View in: PubMed
    Score: 0.012
  9. Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts. Carcinogenesis. 2012 Oct; 33(10):1930-9.
    View in: PubMed
    Score: 0.010
  10. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol Cell Biol. 2012 Jul; 32(13):2570-84.
    View in: PubMed
    Score: 0.010
  11. Estrogen receptor-ß protects against colitis-associated neoplasia in mice. Int J Cancer. 2012 Dec 01; 131(11):2553-61.
    View in: PubMed
    Score: 0.010
  12. AMP-18 facilitates assembly and stabilization of tight junctions to protect the colonic mucosal barrier. Inflamm Bowel Dis. 2012 Sep; 18(9):1749-59.
    View in: PubMed
    Score: 0.010
  13. American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR. BMC Complement Altern Med. 2011 Nov 09; 11:111.
    View in: PubMed
    Score: 0.010
  14. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res. 2011 Jul; 9(7):960-75.
    View in: PubMed
    Score: 0.009
  15. High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis. Magn Reson Med. 2010 Apr; 63(4):922-9.
    View in: PubMed
    Score: 0.009
  16. Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2. Clin Cancer Res. 2009 Nov 15; 15(22):6780-9.
    View in: PubMed
    Score: 0.008
  17. Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer. Carcinogenesis. 2009 Jan; 30(1):175-82.
    View in: PubMed
    Score: 0.008
  18. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. 2008 May 15; 3(5):304-15.
    View in: PubMed
    Score: 0.008
  19. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008 Jan; 294(1):G208-16.
    View in: PubMed
    Score: 0.007
  20. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res. 2007 Oct; 142(2):239-45.
    View in: PubMed
    Score: 0.007
  21. Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res. 2007 Jan 15; 67(2):827-35.
    View in: PubMed
    Score: 0.007
  22. Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands. Psychopharmacology (Berl). 2005 Dec; 183(2):226-40.
    View in: PubMed
    Score: 0.006
  23. Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344. J Pharmacol Exp Ther. 2006 Feb; 316(2):905-13.
    View in: PubMed
    Score: 0.006
  24. The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis. Cancer Lett. 2005 Jan 20; 217(2):161-9.
    View in: PubMed
    Score: 0.006
  25. Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice. Cancer Lett. 2004 Nov 08; 215(1):35-42.
    View in: PubMed
    Score: 0.006
  26. Down-regulation of SNAIL suppresses MIN mouse tumorigenesis: modulation of apoptosis, proliferation, and fractal dimension. Mol Cancer Ther. 2004 Sep; 3(9):1159-65.
    View in: PubMed
    Score: 0.006
  27. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant. 2003 Sep; 3(9):1091-8.
    View in: PubMed
    Score: 0.005
  28. Role of 4-1BB in allograft rejection mediated by CD8+ T cells. Am J Transplant. 2003 May; 3(5):543-51.
    View in: PubMed
    Score: 0.005
  29. Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies. Clin Diagn Lab Immunol. 2002 Mar; 9(2):446-52.
    View in: PubMed
    Score: 0.005
  30. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation. 2001 May 15; 71(9):1351-4.
    View in: PubMed
    Score: 0.005
  31. Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):418-20.
    View in: PubMed
    Score: 0.005
  32. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol. 1999 Sep 01; 163(5):2358-62.
    View in: PubMed
    Score: 0.004
  33. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41.
    View in: PubMed
    Score: 0.004
  34. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation. 1999 Jan 15; 67(1):131-7.
    View in: PubMed
    Score: 0.004
  35. Modified surgical model of paratopic small bowel transplantation in mice. J Surg Res. 1998 Dec; 80(2):188-93.
    View in: PubMed
    Score: 0.004
  36. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts. Transplant Proc. 1998 Sep; 30(6):2592-3.
    View in: PubMed
    Score: 0.004
  37. Inhibition of intestinal allograft rejection by an anti-CD8 monoclonal antibody is not mediated by depletion alone. Transplant Proc. 1998 Jun; 30(4):1069-70.
    View in: PubMed
    Score: 0.004
  38. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation. 1997 Oct 15; 64(7):959-65.
    View in: PubMed
    Score: 0.004
  39. Carcinoembryonic antigen family: expression in a mouse L-cell transfectant and characterization of a partial cDNA in bacteriophage lambda gt11. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5350-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.